Analystreport

TRACON Pharmaceuticals Inc (NASDAQ: TCON) was upgraded by analysts at ValuEngine from a "buy" rating to a "strong-buy" rating.

TRACON Pharmaceuticals, Inc.  (TCON) 
Last tracon pharmaceuticals, inc. earnings: 2/27 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: traconpharma.com